Flaxseed-derived enterolactone is inversely associated with tumor cell proliferation in men with localized prostate cancer

Journal of Medicinal Food

Volumn 16, Issue 4, 2013, Pages 357-360

  Azrad, Maria ^a   Vollmer, Robin T ^b,c   Madden, John ^b   Dewhirst, Mark ^b   Polascik, Thomas J ^b   Snyder, Denise C ^d   Ruffin, Mack T ^e   Moul, Judd W ^b   Brenner, Dean E ^e,f   Demark Wahnefried, Wendy ^a,d  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

diet; flaxseed; lignans; phytoestrogens; prostatic neoplasia

Indexed keywords

ENTERODIOL; ENTEROLACTONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KI 67 ANTIGEN; VASCULOTROPIN;

ADULT; ARTICLE; CELL PROLIFERATION; DIET SUPPLEMENTATION; HUMAN; HUMAN TISSUE; LINSEED; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

4-BUTYROLACTONE; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOLOGICAL MARKERS; CELL PROLIFERATION; DIETARY SUPPLEMENTS; FLAX; HUMANS; KI-67 ANTIGEN; LIGNANS; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; PROSTATIC NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

BRASSICA OLERACEA VAR. ITALICA; MAMMALIA; SESAMUM INDICUM;

EID: 84876118409     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2012.0159     Document Type: Article

References (24)

1. Thompson L: Flaxseed, Lignans, and Cancer, 2nd ed. AOCS Press, Champaign, IL, USA, 2004, pp.194-222
2. Borriello SP, Setchell KD, Axelson M, Lawson AM: Production and metabolism of lignans by the human faecal flora. J Appl Bacteriol 1985;58:37-43
3. Adolphe JL, Whiting SJ, Juurlink BH, Thorpe LU, Alcorn J: Health effects with consumption of the flax lignan secoisolariciresinol diglucoside. Br J Nutr 2010;103:929-938
4. Buck K, Zaineddin AK, Vrieling A, Linseisen J, Chang-Claude J: Meta-Analyses of lignans and enterolignans in relation to breast cancer risk. Am J Clin Nutr 2010;92:141-153
5. McCann SE, Hootman KC, Weaver AM, et al.: Dietary intakes of total and specific lignans are associated with clinical breast tumor characteristics. J Nutr 2012;142:91-98
6. Hedelin M, Klint A, Chang ET, et al.: Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: The cancer prostate Sweden study (Sweden). Cancer Causes Control 2006;17:169-180
7. Heald CL, Ritchie MR, Bolton-Smith C, Morton MS, Alexander FE: Phyto-oestrogens and risk of prostate cancer in Scottish men. Br J Nutr 2007;98:388-396
8. Nam NH: Naturally occurring NF-kappaB inhibitors. Mini Rev Med Chem 2006;6:945-951
9. Corsini E, Dell'Agli M, Facchi A, et al.: Enterodiol and enterolactone modulate the immune response by acting on nuclear factor-kappaB (NF-kappaB) signaling. J Agric Food Chem 2010;58:6678-6684
10. Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-364
11. Bergman Jungeström M, Thompson LU, Dabrosin C: Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo. Clin Cancer Res 2007;13:1061-1067
12. Dabrosin C, Chen J, Wang L, Thompson LU: Flaxseed inhibits metastasis and decreases extracellular vascular endothelial growth factor in human breast cancer xenografts. Cancer Lett 2002;185:31-37
13. A ° berg UW, Saarinen N, Abrahamsson A, Nurmi T, Engblom S, Dabrosin C: Tamoxifen and flaxseed alter angiogenesis regulators in normal human breast tissue in vivo. PLoS One 2011;6:e25720
14. Hanahan D, Weinberg RA: Hallmarks of cancer: The next generation. Cell 2011;144:646-674
15. Thompson LU, Chen JM, Li T, Strasser-Weippl K, Goss PE: Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin Cancer Res 2005;11:3828-3835
16. Fabian CJ, Kimler BF, Zalles CM, et al.: Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside. Cancer Prev Res 2010;3:1342-1350
17. Demark-Wahnefried W, Polascik TJ, George SL, et al.: Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. Cancer Epidemiol Biomarkers Prev 2008;17:3577-3587
18. Subar AF, Thompson FE, Kipnis V, et al.: Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires: The Eating at America's Table Study. Am J Epidemiol 2001;154:1089-1099
19. Thompson LU, Boucher BA, Liu Z, Cotterchio M, Kreiger N: Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan. Nutr Cancer 2006;54:184-201
20. Morton MS, Chan PS, Cheng C, et al.: Lignans and isoflavonoids in plasma and prostatic fluid in men: Samples from Portugal, Hong Kong, and the United Kingdom. Prostate 1997;32:122-128
21. Heymach JV, Shackleford TJ, Tran HT, et al.: Effect of low-fat diet on plasma levels of NF-{kappa}B-regulated inflammatory cytokines and angiogenic factors in men with prostate cancer. Cancer Prev Res 2011;4:1590-1598
22. Buck K, Vrieling A, Zaineddin AK, et al.: Serum enterolactone and prognosis of postmenopausal breast cancer. J Clin Oncol 2011;29:3730-3738
23. Grace PB, Taylor JI, Low YL, et al:. Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutritionnorfolk. Cancer Epidemiol Biomarkers Prev 2004;13:698-708
24. Adlercreutz H: Phytoestrogens: Epidemiology and a possible role in cancer protection. Environ Health Perspect 1995; 103(Suppl 7):103-112